Pharmaceuticals 2024—Recent Advances in Pharmaceutical Sciences Towards a Healthy Life
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 26
Special Issue Editors
Interests: neurodegenerative diseases; organic synthesis; natural products; antibiotics; antidiabetics; carbohydrate chemistry
Special Issues, Collections and Topics in MDPI journals
Interests: antisense; aptamers; RNA virus; genomic RNAs; HCV genome; HIV genome; structure/function of RNA domains; coronavirus
Special Issues, Collections and Topics in MDPI journals
Interests: drug development; antiestrogens; in silico; breast cancer; design and synthesis, synthetic methods; amphetamines; anticancer drug design; carbapenem antibiotics; chemistry of drug metabolism; chemistry of drug receptor interactions; design and synthesis of drugs; molecular modelling of estrogen receptor antagonists; pharmacologically active heterocycles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is related to the conference “Pharmaceuticals 2024—Recent Advances in Pharmaceutical Sciences Towards a Healthy Life”, which will be held in Barcelona, Spain, 27–29 November 2024.
Covering the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others, the meeting will bring experts together to present their latest findings on relevant topics such as combating infection, inflammation, pain, and neurodegeneration.
In this meeting, we encourage participation from all areas of pharmaceutical research to highlight recent advances in the field of applied chemistry in the search for novel solutions to global pharmaceutical challenges. This conference will provide the opportunity to finally meet in person and bring together younger researchers, experts, and industry to plan science and technology for the future. A roundtable will be organized to start and facilitate further discussions.
Conference participants, as well as all researchers working in the field, are invited to contribute original research papers or reviews to this Special Issue of Pharmaceuticals.
Prof. Dr. Amélia Pilar Rauter
Dr. Alfredo Berzal-Herranz
Prof. Dr. Mary J. Meegan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry
- natural products
- organic synthesis
- radiopharmaceuticals
- pharmacology
- toxicology
- glycosciences
